Mylan reaches $4.5m settlement with Maryland over EpiPen prices
MLex Summary: Mylan has agreed to pay $4.5 million to resolve resolving concerns brought by the Maryland Attorney General about anticompetitive conduct involving the cost, marketing, and availability of EpiPen products....To view the full article, register now.
Already a subscriber? Click here to view full article